High-risk nonsteroidal anti-inflammatory drug use declined modestly in Virginia during the COVID-19 pandemic but remained prevalent from 2019 to 2021. Demographic disparities reveal distinct opportunities for targeted deprescribing interventions.
Alexandra L. Hanlon, PhD
Advertisement
Articles by Alexandra L. Hanlon, PhD
A retrospective analysis of 30-day risk-adjusted readmission rates among skilled nursing facilities (SNFs) between 2017 and 2022 compared those that had implemented an interventional analytics platform and other SNFs.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
2
5 Things to Know About the FDA's Peptide Reversal
3
Contributor: The Deadly Gap in the Charity Care System
4
Iberdomide Complements CAR T in Myeloma: Swarup Kimar, MD
5